During the past decade, Providence Milwaukie Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 89 clinical trials were completed, i.e. on average, 2225% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 25 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Milwaukie Hospital" #1 sponsor was "SWOG Cancer Research Network" with 50 trials, followed by "National Cancer Institute (NCI)" with 42 trials sponsored, "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "Radiation Therapy Oncology Group" with 10 trials sponsored and "NSABP Foundation Inc" with 10 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Milwaukie Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Providence Milwaukie Hospital" are "Breast Cancer" (28 trials), "Lymphoma" (15 trials), "Lung Cancer" (12 trials), "Leukemia" (6 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Providence Milwaukie Hospital" in a lesser frequency.

Most popular intervention types in "Providence Milwaukie Hospital" are "Drug" (119 trials), "Other" (65 trials), "Biological" (48 trials), "Radiation" (27 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Quality-of-Life Assessment" (17 trials), "placebo" (15 trials), "Bevacizumab" (12 trials) and "cyclophosphamide" (11 trials). Other intervention names were less common.

The vast majority of trials in "Providence Milwaukie Hospital" are 110 trials for "All" genders, 32 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Milwaukie Hospital". undefined are not yet recruiting, undefined are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 92 completed trials in Providence Milwaukie Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Milwaukie Hospital, 5 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".